可注射的细胞外囊泡水凝具有可调节的粘弹性,用于仓库疫苗
Rimsha Bhatta1, Joonsu Han1, Yusheng Liu1
1Department of Materials Science and Engineering, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
Nature communications
|April 22, 2025
概括
研究人员开发了可注射的细胞外囊泡 (EV) 水凝,以改善癌症治疗. 这些EV水凝增强免疫细胞的吸引力和T细胞的启动,为药物输送和治疗提供了一个有前途的平台.
科学领域:
- 生物技术是生物技术.
- 材料科学 材料科学 材料科学
- 免疫学 免疫学 免疫学
背景情况:
- 细胞外囊泡 (EVs) 显示治疗潜力,但患有组织保留不良.
- 有限的保留阻碍了基于EV的癌症和其他疾病治疗的临床转化.
研究的目的:
- 开发可注射的细胞外囊泡 (EV) 水凝,具有可调节的特性,以提高治疗疗效.
- 提高EVs的组织保留和免疫调节能力.
主要方法:
- 使用点击化学方法,与含有二子环氧素的聚乙烯甘醇进行了交叉链接,对具有阿齐多群的代谢标记的EV进行了交叉链接.
- 制造的注射EV水凝具有可调节的粘弹性和凝温度 (39.4°C).
- 评估了体内稳定性,免疫细胞吸引力,抗原呈现和与抗PD-1疗法的治疗协同作用.
主要成果:
- 在注射后EVs在现场凝结,形成稳定的水凝超过4周.
- EV水凝吸引了免疫细胞,包括树突细胞,并作为长期存储瘤抗原.
- 瘤EV水凝增强了CD8+T细胞的原始化,与抗PD-1疗法产生了协同作用,并重新编程了瘤微环境.
- 与溶液形式的EV相比,EV水凝诱导了增强的抗体反应.
结论:
- 建立了一种简单且通用的方法,用于制造具有可调节机制的注射EV水凝.
- 通过增强保留和免疫调节,EV水凝显著提高了基于EV的治疗疗效.
- 这种方法为推进基于EV的疗法在瘤学及其他领域提供了一个有前途的战略.
相关概念视频
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:28Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...